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Cats and Pharmaceuticals
Nina Shoulberg, D.V.M ., M.S. and Wayne S. Schwark, D .V.M ., Ph.D.
With the increasing popularity of cats as 
housepets, it is inevitable that the 
veterinary practitioner will have occasion 
to use drugs in a greater number of feline 
patients in the future. Considering the 
cat’s unique deficiencies in capacity for 
drug metabolism, it is essential that cats 
not be thought of as simply "small dogs" 
when medicated. It is the aim of this 
article to discuss certain compounds which 
are considered to be relatively safe in 
other species but which are toxic to cats. 
These drugs are some of the most poten­
tially dangerous because an unsuspecting 
practitioner who has had little trouble 
with the drug in a dog might be tempted to 
use it without caution in a cat.
Because the pharmacological and toxico- 
logical effcts of a chemical substance are 
usually directly proportional to the 
concentration of that compound in the 
animal's body fluids and tissues, pharma­
cokinetic factors are of primary impor­
tance in determining responses to exogen­
ous chemicals. The concentration of a 
given compound in an animal's body fluids 
and tissues is determined by its dosage
and pharmaceutical form, as well as the 
absorption, distribution, biotransforma­
tion, and excretory properties of the 
drug.
It has become increasingly apparent 
that cats differ markedly from other 
species in the rate at which they bio- 
metabolize compounds and that this often 
accounts for their unique sensitivity to 
many drugs and chemicals. Biotransforma­
tion is usually a two-step process involv­
ing oxidation, reduction or hydrolysis
followed by conjugation of a compound. 
These processes occur for the most part in 
the liver, utilizing enzymes associated 
with the smooth endoplasmic reticulum of 
the hepatocyte. Metabolites are formed 
which may have activities similar to or 
markedly different from that of the parent 
compound. These drug metabolites tend to 
be more polar and less lipophilic than the 
original drug and hence are more readily 
excreted from the body. Among the common 
domestic animals, cats are unique in that 
they have low levels of hepatic glucuronyl 
transferase, an enzyme essential for the 
conjugation of compounds such as alcohols, 
phenols, carboxylic acids, amines, amides, 
and thiols with glucuronic acid. Examples 
of drugs representing these groups of 
compounds include morphine, acetaminophen, 
acetylsalicylic acid, and chloramphenicol. 
Hence, a decreased ability to convert 
these drugs into inactive, readily excret- 
able metabolites explains, at least in 
part, the observed accumulation and toxic­
ity of drugs such as these in cats.
Analgesics
Acetylsalicylic acid (aspirin), an over- 
the-counter pharmaceutical, is a common 
cause of poisoning in the cat. Daily 
administration of less than one-half of an 
adult human aspirin (2 grains) can produce 
intoxication within one to two days in 
cats. Clinical signs include anorexia and 
depression progressing to vomiting after 
approximately the fourth dose. Higher 
levels of the drug produce more intense 
toxic effects, such as hematological 
disorders, fever, dyspnea, acid-base
(Continued on page 3.)
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Feline Advisory Council Welcomes New Members
Six new members have been ap­
pointed this year to the Cornell 
Feline Health Center Advisory 
Council, contributing a broad 
spectrum of interests and per­
spectives to the development of 
feline programs. We are happy to 
welcome Joan M. Arnoldi, D.V.M.,
President of the American Asso­
ciation of Feline Practitioners;
Nancy A. Bull, President and 
Managing Publisher of Veterinary 
Practice Publishing Co.; Roger 
Caras, noted author and Special 
Correspondent on Animals and the 
Environment for ABC News; Mark 
L. Morris, Jr., D.V.M., Trustee and Research Vice President of the Morris Animal Foun­
dation; Mordecai Siegal, TV talk show personality and award-winning author of numerous 
books and columns on pets; and Joan Wastlhuber, President of the Robert H. Winn Founda­
tion for Cat Research.
They join fellow members George W. Abbott, D.V.M., and Jean Holzworth, D.V.M., of 
Angell Memorial Animal Hospital; John M. Brentlinger, Jr.; Sally Faile El-Sayed; Hazel 
Lindstrand, Cat Fanciers Association Shorthair Judge; Rosemonde Peltz, M.D.; Theodore 
A. Rude, V.M.D., Assistant to the President of Salsbury Laboratories; and Ellen Yanow, 
Executive Director of Tree House Animal Foundation.
The Annual Meeting was held in June. Pictured from left are Dr. Arnoldi, Ms. Yanow, 
Ms. Bull, Ms. Wastlhuber (seated), Mr. Siegal (seated), Dr. Rude, and Dr. Morris.
Correction
The dose of pancuronium listed in "A Guide 
to Feline Anesthesia," on page 7 in the 
Spring 1984 issue of "Veterinary News," 
should have been 0.03 mg/lb. IV, rather 
than 0.3 mg/lb. IV.
In many cases, a tenfold error in the 
administered dose of a drug will produce a 
serious threat to the well-being of the 
animal receiving it; fortunately, this 
does not appear to occur with pancuronium 
use in cats. Although the dose required 
to produce neuromuscular blockade in most 
anesthetized cats is 0.03 mg/lb., much 
higher doses are tolerated without toxic 
effects as long as ventilatory support is 
provided. This high margin of safety, 
along with the reversibility of the drug, 
would seem to make pancuronium the drug of 
choice for producing neuromuscular block­
ade in the cat.
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disturbances, possibly convulsions, and 
death.
Treatment of aspirin intoxication is 
basically supportive. Fluid therapy is 
complicated by the fact that the cat may 
be either in respiratory alkalosis or, as 
the intoxication progresses, in metabolic 
acidosis. A practitioner can circumvent 
the uncertainty of acid-base status by 
using a Harleco apparatus to determine the 
metabolic state of the animal. If aspirin 
ingestion is relatively recent, emesis or 
enterogastric lavage may be indicated. 
Alkalinizing the urine to a pH greater 
than 8 will hasten the excretion of the 
aspirin and help correct the metabolic 
acidosis which is most commonly present.
Analgesics even more dangerous to cats 
are acetaminophen (Tylenol®) and phena- 
cetin (a compound which is converted to 
acetaminophen in the liver). One Extra 
Strength Tylenol® (500 mg) or two Regular 
Strength Tylenol® capsules (325 mg) given 
four hours apart may produce toxicity in 
cats with clinical signs such as depres­
sion, anorexia, shallow respiration, pale 
cyanotic mucous membranes, icterus, vomit­
ing, limb and facial edema, and dark, 
chocolate-colored urine. Methemoglobine­
mia, as evidenced by chocolate-colored 
blood, is a common factor of this toxic­
ity. If the toxicity is left untreated, 
death may occur within three days post­
administration.
Treatment of acetaminophen intoxication 
is supportive, possibly entailing the use 
of blood transfusions. Additionally, 
acetylcysteine has been advocated as a 
specific antidote. The rationale for the 
use of this drug relates to the feline's 
deficient glucuronyl transferase system. 
Due to the cat's inadequacies in conjugat­
ing acetaminophen metabolites with glucur- 
onide, a larger proportion of a toxic 
reactive metabolite, N-acetyl-p-benzoqui- 
none, is formed. This metabolite is 
subsequently inactivated by conjugation 
with endogenous hepatic glutathione by an 
alternate enzyme system. When the gluta­
thione is depleted, cellular damage ensues 
due to the unbound reactive metabolite. 
Acetylcysteine, a compound similar in 
structure to glutathione, is given in an 
effort to provide an exogenous substrate 
for the metabolite. It is available to 
the practitioner as Mucomyst® and is pro­
vided as a 20% solution. The recommended 
treatment regime for acetaminophen intoxi­
cation is 0.7 ml/kg orally given on admis­
sion, followed by a similar dosage at 
four, 12, and 20 hours thereafter.
Clinical experience indicates that 
phenylbutazone is also more toxic in cats 
than in other species. Acceptable treat­
ment regimes with this drug as well as 
other newer nonsteroidal antiinflammatory 
drugs such as flunixin meglumide (Bana- 
mine®) have not been established in the 
feline.
Fortunately, acceptable narcotic anal­
gesics are available for the management of 
acute pain situations in the feline. Mor­
phine, when given at the dosage suitable 
for dogs (1 mg/kg), may produce severe CNS 
stimulation in cats. However, when admin­
istered at a reduced dosage, morphine is 
an effective, safe analgesic in the cat. 
The recommended dosage of 0.1 mg/kg SC 
will produce analgesia for over four 
hours. Dextro-propoxyphene hydrochloride 
(Darvon®), a synthetic narcotic similar to 
methadone, given at 2.2 mg/kg IM, also 
produces acceptable, safe analgesia within 
two hours, with a duration of greater than 
four hours. Meperidine (Demerol®), with a 
plasma half-life of only 0.7 hours, pro­
duces acceptable analgesia two hours 
following IM injection of 11 mg/kg (this 
dose being comparable to that used in a 
dog). Unfortunately the analgesic effects 
of meperidine are short-lived and by four 
hours pain sensation returns. Finally, a 
newer semisynthetic narcotic analgesic, 
oxymorphone (Numorphan®), at a dosage of 
0.4 to 1.5 mg/cat SC, IM, or IV, produces 
satisfactory analgesia. An obvious disad­
vantage of these narcotic compounds is the 
fact that they are controlled substances; 
however, they do represent effective 
choices for acute pain management in the 
cat.
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A n tib io tic s
Controversy has long existed over the use 
of chloramphenicol in cats. The rare, 
idiosyncratic, nondose-related agranulocy­
tosis and aplastic anemia seen in human 
patients has not been reported in the 
feline. However, cats are susceptible to 
the dose-dependent bone marrow depression 
and blood dyscrasias reported in other 
species because this drug is highly 
dependent on hepatic biotransformation for 
elimination from the body. Perhaps a more 
significant clinical consequence of chlor­
amphenicol administration is anorexia. In 
an already debilitated patient, this may 
be life-threatening. Hence, it is desir­
able (if chloramphenicol must be used) 
that a minimum acceptable regime of ther­
apy be employed with regard to both dosage 
and total duration of therapy. A dosage 
of 13 to 20 mg/kg orally B.I.D. (versus 
the recommended dose of 20 mg/kg T.I.D.) 
has been shown to produce therapeutically 
effective plasma chloramphenicol levels 
and may represent an acceptable treatment 
regime.
Streptomycin and dihydrostreptomycin 
may produce neurotoxic effects in cats. 
Respiratory failure due to neuromuscular 
blockage may be induced by high doses (150 
mg/kg IV) of streptomycin. Repeated smal­
ler doses (50 mg/kg) given IM produce 
ataxia, gait and postural alterations, and 
disappearance of the normal rotational 
nystagmus; hearing is also reported to be 
affected. It should be noted that all 
aminoglycoside antibiotics (streptomycin, 
dihydrostreptomycin, kanamycin, neomycin, 
and gentamycin) have been shown to cause 
either vestibular lesions or renal tubular 
damage in dogs and cats when used for 
prolonged periods of time. Veterinarians 
should use this group of antibiotics 
cautiously in both species, particularly 
when any degree of renal impairment is 
present, for these drugs are eliminated by 
direct renal excretion.
A n tip a ra s it ic s
Clinical impressions indicate that cats
are highly sensitive to organophosphates. 
In acute organophosphate intoxication, 
signs referrable to acetylcholine accumu­
lation are produced: miosis, frequent
defecation and urination, salivation, 
vomiting, muscle fasciculations, convul­
sions, and death due to respiratory paral­
ysis. Signs may be seen from minutes to 
in excess of 24 hours post-exposure. 
Additionally, cats appear to be more 
susceptible to the delayed form of neuro­
toxicity, in which minimal exposure to an 
organophosphate results in axonal degener­
ation days to weeks later. The degenera­
tion and consequent signs of paresis and 
paralysis begin peripherally and progress 
toward the central nervous system. It is 
not known why cats are more susceptible 
than most other domestic animals to this 
form of toxicity. Finally, dichlorvos- 
impregnated flea collars have been report­
ed to cause contact dermatitis in cats and 
should be used with particular caution in 
debilitated cats.
Treatment of acute organophosphate 
intoxication is supportive and may entail 
the use of enterogastric lavage. Addi­
tionally, atropine at 0.1 to 0.2 mg/kg 
given slowly IV is a specific antidote. 
To avoid ventricular fibrillation, atro­
pine should not be given to a cyanotic 
patient; rather resuscitative efforts 
should be instituted first. In more seri­
ous cases of poisoning, IV 2-PAM at 20 
mg/kg should be given in conjunction with 
atropine.
Malathion is one organophosphate 
approved for use in cats and considered 
safe and efficacious for the treatment of 
ectoparasites. Its rapid metabolism in 
mammals compared to insects may account 
for the increased safety relative to other 
organophosphates.
Cats appear to be very sensitive to 
chlorinated hydrocarbons, thus their use 
is contraindicated. Chlordane, lindane, 
dieldrin, aldrin, and endrin cause 
apprehension, belligerence, hyperesthesia, 
hypersalivation, convulsion, and death in 
cats. These signs may occur from minutes
5to weeks post-exposure and the clinical 
course of the intoxication may be 
prolonged, for these compounds are readily 
stored in fat depots. Treatment entails 
washing the product off the fur and/or 
enterogastric lavage. Additionally,
sedation with diazepam and housing the 
animal in a dark, quiet environment are 
recommended to control seizure activity. 
Because chlorinated hydrocarbons are 
excreted by the kidneys, it is important 
that adequate urine production be 
maintained.
Miscellaneous Drugs
Griseofulvin induces teratogenic effects 
when given to pregnant queens; therefore 
its use in these animals is not recommend­
ed. Animals are particularly vulnerable 
during the first trimester of pregnancy, 
when multiple malformations including 
cleft palate, cyclopia, and exencephaly 
are produced. Treatment during the third 
or fourth week of gestation may result in 
weak or stillborn festuses; however, 
treatment during the last half of pregnan­
cy is apparently without ill effects on 
the fetus.
Urinary antiseptics containing meth­
ylene blue may cause a severe Heinz body 
hemolytic anemia and concurrent pallor, 
icterus, dyspnea, depression, and death if 
left untreated. Blue urine and feces may 
be one of the presenting signs. Methylene 
blue causes an irreversible oxidation of 
the hemoglobin molecule leading to the 
formation of Heinz bodies in the red blood 
cells. These cells then undergo intravas- 
cular hemolysis to produce the observed 
clinical signs.
Phosphate-containing enemas (e.g., 
Fleet®) may produce profound depression, 
collapse, violent vomition, hypersaliva­
tion, tachycardia, cyanosis, hypothermia, 
muscle fasciculations, and tetany within 
20 minutes post-administration; their use 
is an absolute contraindication in cats. 
Serum electrolyte analysis at the time of 
presentation will show a severe hypocalce­
mia, hyperphosphatemia, and hypernatremia.
Treatment is aimed at restoring the serum 
calcium levels to normal. Initially, a 
10% solution of calcium gluconate should 
be administered slowly IV. Given until 
the tetany and muscle fasciculations have 
ceased, this approximates a dose of 1.5 
ml/kg. Concurrent EKG monitoring is 
advised during calcium administration. 
The cat should then be put on a mainte­
nance drip of 5% dextrose in water supple­
mented with 10% calcium gluconate. Serum 
calcium levels should be monitored daily 
and the drip discontinued when calcium 
levels return to normal.
A decreased ability to conjugate phe­
nols with glucuronic acid and the subse­
quent buildup of toxic quinones explains 
the cat's generalized sensitivity to 
phenol-containing compounds. One example 
of such a product is hexachlorophene. 
Used in germicidal soaps (e.g., Septi- 
sol®), hexachlorophene may be potentially 
toxic if incorporated into enemas or used 
as a surgical scrub. Because it is readi­
ly absorbed from the skin and digestive 
tract, it may cause the following clinical 
signs: vomiting, depression, ataxia,
patellar hyperreflexia progressing to 
hyporeflexia, anuria, and flaccid paraly­
sis. Treatment is supportive and may 
entail gastric lavage or administration of 
a saline cathartic. In addition, manage­
ment of cerebral edema may be necessary.
Finally, benzyl alcohol, used as a 
preservative in many solutions for paren­
teral administration, may be toxic to cats 
if given in excessive amounts. Small 
amounts can be conjugated by the cat's 
glucuronyl transferase system but quanti­
ties such as those involved in fluid 
replacement therapy cannot be effectively 
eliminated. A toxic metabolite, benzoic 
acid, accumulates and causes the central 
signs of ataxia, hyperesthesia, muscle 
fasciculations, and depression. Overzeal- 
ous use of solutions containing benzyl 
alcohol as a preservative should therefore 
be avoided in cats.
Much research needs to be done to
(Continued on page 8.)
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Feline Diagnostic Services at Cornell
Guidelines for Submission of Samples to the Diagnostic Laboratory
Cheryl A. Stoddart, M.S.
Many practitioners contact the Cornell 
Feline Health Center for advice on prob­
lematic cases, most frequently feline 
leukemia, feline infectious peritonitis, 
chronic upper respiratory disease, gastro­
intestinal disorders, reproductive
problems, and kitten mortality. In re­
sponse, we often recommend that specific 
diagnostic tests be performed to determine 
the cause and facilitate treatment. Un­
fortunately, not all veterinarians are 
aware of the correct procedures for 
collection and submission of samples for 
these specific tests and, as a result, 
they may neglect to have these crucial 
tests performed, incur unnecessary delays, 
or obtain false results. This article is 
an attempt to familiarize readers with the 
proper procedures for collection and 
submission of samples, and to encourage 
practitioners to more fully utilize the 
Diagnostic Laboratory at Cornell.
Before submitting samples the most 
important step is to write or call the 
Diagnostic Laboratory to obtain 1) their 
Policy and Fee Schedule, 2) a pad of 
submission forms, and 3) supply request 
forms (all available free of charge). The 
Policy and Fee schedule lists the current­
ly available tests and contains detailed 
information concerning sample submission 
for each individual test. By using the 
supply request form, you can order (for 
nominal fees) most of the items needed for 
proper sample submission. Such available 
items mentioned in this article are denot­
ed with an asterisk (*).
Sample Collection
Choose samples judiciously according to 
the nature of the disease: serum samples 
for antibody, feline leukemia virus, and 
hormone baseline/response tests; conjunc­
tival, pharyngeal, and nasal swabs (upper 
respiratory disease) and vaginal and 
uterine swabs (reproductive problems) for 
isolation of bacteria and viruses; fecal 
samples and intestinal scrapings (gastro­
intestinal disorders) for parasite examin­
ation, bacteria culture, and electron 
microscopy; and tissue samples (from 
biopsy or necropsy) for histopathology and 
virus isolation.
Serum: Allow the blood sample to clot
at room temperature (two hours) and for 
greatest serum yield, place it in the 
refrigerator overnight. The clot will 
then retract. Aseptically transfer the 
serum (approximately 1 ml per test) to a 
sterile vial*. (If a centrifuge is avail­
able, spin down the clot; if not, careful­
ly remove the serum from around the clot 
with a pipette). Refrigerate the vials 
and ship in a styrofoam blood-tube mailer* 
or in a styrofoam "biomailer"* with cold- 
packs. (Save the cold-packs from vaccine 
shipments for this purpose). In the case 
of antibody tests for cats which show 
clinical signs, it is helpful to submit 
paired serum samples obtained three to 
four weeks apart; active infection is 
demonstrated when a marked (fourfold or 
more) increase in titer occurs over time. 
The first sample must be collected as 
early in the acute phase of the disease as 
possible and the second during convales­
cence. To avoid confusion, freeze the 
first sample and retain it until the 
second sample is obtained, at which time 
both can be submitted together. For 
healthy cats of unknown prior infection 
status, a test on a single sample will 
provide useful information. Additionally, 
a very high titer on a single sample, when 
consistent with clinical signs, is suppor­
tive of the presumptive diagnosis.
Swabs: Place swabs for bacteria cul-
7ture in sterile vials containing the 
transport medium specific for the organism 
to be isolated, i.e.; Amies transport 
medium* or "culturettes" for aerobic 
bacteria, mycoplasma, and ureaplasma; 
anaerobic bacteria transport medium*; and 
chlamydia transport medium*. Refrigerate 
the vials and send them in a biomailer* 
with cold-packs situated in such a manner 
that the samples do not freeze. A separ­
ate set of swabs can be submitted for 
virus isolation in a viral transport 
medium.* If these are to be shipped over­
night, they should be sent with cold- 
packs. If there is to be a delay in ship­
ment, they should be frozen and shipped 
frozen. Use of dry ice (difficult to 
obtain but sometimes available from ice 
cream companies) in the biomailer will 
ensure against thawing of samples. If dry 
Ice is used, seal vials in Ziploc® bags to 
prevent the CO 2  from inactivating the 
virus. Remember: DO NOT use virus trans­
port medium for swabs submitted for bac­
teria culture or for chlamydia, and DO NOT 
use bacteria transport medium for virus 
isolation, because this will preclude 
successful isolations.
Fecal samples: For bacteria and virus
culture, place 1 to 5 gm fresh feces in a 
sterile wide-mouth sealed container* and 
send on cold-packs without preservative or 
fixative. Samples for electron microscopy 
(2 gm) should also be sent cold but not 
frozen. If feces are liquid and a delay 
in transport is anticipated, several drops 
of 10% formalin can be added. For para­
site screen, feces can be preserved by 
adding 3 to 5 gm to 10 volumes of 10% 
formalin. (Formalin can be obtained from 
a veterinary supplier or pharmacy.) Fecal 
samples should be collected within 24 
hours of the acute phase of disease and 
not after two to three weeks of unsuccess­
ful treatment.
Tissues: Collect fresh samples 0.5 to
2.0 cm thick from tissues demonstrating 
macroscopic lesions, including the periph­
ery of the lesion as well as some sur­
rounding normal tissue. If lesions are 
not evident, as is usually the case with 
kittens dying from "fading kitten syn­
drome," a variety of tissues should be 
obtained (thymus, lung, heart, liver, 
spleen, kidney, lymph node, intestine, 
etc.). If tissues are to be submitted for 
both virus isolation and histopathology, 
you MUST submit DIFFERENT SETS of tissues 
for each because of drastically different 
submission procedures. The set for histo­
pathology must not be frozen and should be 
placed in a wide-mouth jar* containing at 
least 10 times the tissue volume of 10% 
neutral-buffered formalin. Refrigeration 
and fast delivery are not necessary but be 
sure to seal the jars tightly to prevent 
evaporation and leakage. The set of 
tissues for virus isolation and immuno­
fluorescence (FA tests) MUST NOT be fixed 
in formalin. Place each tissue in indivi­
dual, labeled containers or plastic 
specimen bags. For FA tests, the tissues 
also should not be frozen, but shipped 
cold, with overnight delivery if possi­
ble. Tissues for virus isolation that are 
shipped for overnight delivery can be sent 
unfrozen with cold-packs. If lengthy 
delays are anticipated, tissues for virus 
isolation should be frozen and shipped to 
arrive frozen.
Sample Submission
Packaging: Label each sample with the
names of the animal, the owner, and veter­
inarian, the date obtained, and the nature 
of the sample or tissue. Make sure con­
tainers are tightly sealed. Fill out the 
submission form completely, including a 
detailed history, and specify the tests 
requested on each sample. If given the 
history, the Diagnostic Laboratory will be 
able to provide a more meaningful inter­
pretation of the test results.
Shipping: Affix a Diagnostic Labora­
tory mailing label* or write the correct 
address on the box. In order to assure 
prompt attention to your sample, send it 
directly to the Diagnostic Laboratory, not 
to the Cornell Feline Health Center or any 
other department. The Feline Health 
Center is not directly associated with the 
Diagnostic Laboratory, and mislabeling of 
packages has resulted in lengthy delays in 
sample processing. It is also important
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that the samples for various isolations be 
shipped early in the week by the fastest 
means possible, i.e., hand delivery or 
overnight mail. DO NOT send the samples 
on Friday or before a holiday. Refriger­
ate or freeze them, whichever is appropri­
ate, until the beginning of the next week 
and then send them.
It is hoped that these brief instruc­
tions will enable you to obtain satisfac­
tory service through proper preparation 
and handling of specimens. For more 
information or to obtain a Policy and Fee 
Schedule, necessary forms, and supplies, 
contact:
Diagnostic Laboratory 
N.Y.S. College of Veterinary Medicine 
at Cornell 
P.O. Box 786 
Ithaca, NY 14851 
(607) 256-6541
Cheryl A. Stoddart (M.S., Cornell '83) is 
working toward a Ph.D. in Veterinary 
Virology, continuing her studies of feline 
infectious peritonitis. She was assisted 
in writing this article by Drs. Richard 
Jacobson, Edward Dubovi, Thomas Reimers, 
and Alfonso Torres, specialists at the 
Diagnostic Laboratory.
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further our understanding of the cat's 
unique sensitivities to drugs. The abili­
ty to design rational dosage regimes with 
drugs depends on information provided by 
sophisticated pharmacokinetic studies, 
which are now becoming more commonplace in 
veterinary medicine. It behooves the 
practitioner to maintain careful scrutiny 
of veterinary journals for reported intox­
ications and to limit his or her armamen­
tarium to those drugs and dosage regimes 
which have been shown to be safe and 
efficacious in cats.
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